Wiley Bros. Aintree Capital, LLC Ishares Biotechnology ETF Transaction History

Wiley Bros. Aintree Capital, LLC

  • $14.9 Billion
  • Q3 2025

A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 15,749 shares of IBB stock, worth $2.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,749
Previous 15,209 3.55%
Holding current value
$2.59 Million
Previous $1.92 Million 18.14%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$127.63 - $144.37 $68,920 - $77,959
540 Added 3.55%
15,749 $2.27 Million
Q2 2025

Aug 14, 2025
BUY
$112.02 - $129.0 $21,843 - $25,155
195 Added 1.3%
15,209 $1.92 Million
Q1 2025

May 15, 2025
BUY
$127.9 - $140.56 $158,212 - $173,872
1,237 Added 8.98%
15,014 $1.92 Million
Q4 2024

Feb 14, 2025
BUY
$131.21 - $148.85 $608,158 - $689,919
4,635 Added 50.7%
13,777 $1.82 Million
Q3 2024

Nov 14, 2024
SELL
$135.09 - $149.47 $194,259 - $214,937
-1,438 Reduced 13.59%
9,142 $1.33 Million
Q2 2024

Jul 23, 2024
BUY
$124.64 - $139.96 $523,114 - $587,412
4,197 Added 65.75%
10,580 $1.45 Million
Q1 2024

Apr 11, 2024
BUY
$132.3 - $140.89 $95,256 - $101,440
720 Added 12.71%
6,383 $875,000
Q4 2023

Jan 08, 2024
SELL
$112.41 - $137.03 $17,198 - $20,965
-153 Reduced 2.63%
5,663 $769,000
Q3 2023

Oct 06, 2023
SELL
$122.27 - $131.47 $122,881 - $132,127
-1,005 Reduced 14.73%
5,816 $711,000
Q2 2023

Jul 05, 2023
BUY
$125.53 - $133.58 $3,765 - $4,007
30 Added 0.44%
6,821 $865,000
Q1 2023

Apr 05, 2023
SELL
$121.97 - $137.23 $8,537 - $9,606
-70 Reduced 1.02%
6,791 $877,000
Q4 2022

Jan 10, 2023
SELL
$117.58 - $138.43 $13,756 - $16,196
-117 Reduced 1.68%
6,861 $0
Q3 2022

Oct 11, 2022
SELL
$113.42 - $134.82 $7,939 - $9,437
-70 Reduced 0.99%
6,978 $816,000
Q1 2021

Apr 09, 2021
BUY
$146.68 - $172.6 $4,253 - $5,005
29 Added 0.41%
7,048 $1.06 Million
Q4 2020

Jan 11, 2021
BUY
$130.38 - $157.31 $22,946 - $27,686
176 Added 2.57%
7,019 $1.06 Million
Q3 2020

Oct 05, 2020
SELL
$126.88 - $145.8 $69,149 - $79,461
-545 Reduced 7.38%
6,843 $927,000
Q2 2020

Jul 07, 2020
SELL
$103.79 - $138.65 $27,815 - $37,158
-268 Reduced 3.5%
7,388 $1.01 Million
Q1 2020

Apr 03, 2020
SELL
$94.39 - $123.48 $35,962 - $47,045
-381 Reduced 4.74%
7,656 $825,000
Q3 2019

Oct 10, 2019
SELL
$99.3 - $105.55 $127,104 - $135,104
-1,280 Reduced 13.74%
8,037 $800,000
Q3 2019

Oct 04, 2019
BUY
$99.3 - $105.55 $43,394 - $46,125
437 Added 4.92%
9,317 $1.14 Million
Q2 2019

Jul 10, 2019
SELL
N/A
-320 Reduced 3.48%
8,880 $969,000
Q1 2019

Apr 08, 2019
SELL
N/A
-827 Reduced 8.25%
9,200 $1.03 Million
Q4 2018

Feb 06, 2019
BUY
N/A
10,027 New
10,027 $967,000

Others Institutions Holding IBB

# of Institutions
963
Shares Held
31.6M
Call Options Held
3.52M
Put Options Held
2.74M
View Full List

About ISHARES BIOTECHNOLOGY ETF

IBB Quotes by TradingView
  • Ticker IBB
  • Sector ETFs
  • Industry ETFs
More about IBB
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email